%0 Journal Article
%T Validation of a New North American Islet Donor Score for Donor Pancreas Selection and Successful Islet Isolation in a Medium
%A Alicja D£¿bska-£¿lizie¨½
%A J. Michael Millis
%A John Fung
%A Justyna E. Go£¿£¿biewska
%A Karolina Go£¿£¿b
%A Lindsay Basto
%A Ling-jia Wang
%A Mark R. Kijek
%A Martin Tibudan
%A Natalie Fillman
%A Piotr J. Bachul
%A Piotr Witkowski
%A Sabrina Matosz
%J Cell Transplantation
%@ 1555-3892
%D 2019
%R 10.1177/0963689718816989
%X The selection of optimal pancreas donors is one of the key factors in determining the ultimate outcome of clinical islet isolation. North American Islet Donor Score (NAIDS) allows for estimating the chance of the success of islet isolation. It was developed based on the data from over 1000 donors from 11 islet isolation centers and validated in the University of Alberta, Edmonton, on the cohort from the most active islet transplant center. Now we aimed to also validate it in our much less active program. Areas under the receiver operating characteristic curves (AUROCs) and logistic regression analyses were obtained to test if NAIDS would better predict successful islet isolation (defined as post-purification islet yield >400,000 islet equivalents (IEQ)) than previously described Edmonton islet donor score (IDS) and our modified version of IDS. We analyzed the donor scores with reference to 82 of our islet isolation outcomes. The success rate increased proportionally as NAIDS increased, from 0% success in NAIDS < 50 points to 40% success in NAIDS ¡Ý 80 points. AUROCs were 0.67 (95% confidence interval (CI) 0.55¨C0.79) for NAIDS, 0.58 (95% CI 0.44¨C0.71) for modified IDS, and 0.51 (95% CI 0.37¨C0.65) for IDS and did not differ significantly. However, based on logistic regression analyses, NAIDS was the only statistically significant predictor of successful isolation (p = 0.01). The main advantage of NAIDS is an enhanced ability to discriminate poor-quality donors than previously used scoring systems at University of Chicago, with 0% chance for success when NAIDS was <50 as compared with 40% success rate for IDS <50. NAIDS was found to be the most useful available tool for donor pancreas selection in clinical and research practice in our center, allowing for identification and rejection of poor-quality donors, saving time and resources
%K scoring system
%K islet isolation
%U https://journals.sagepub.com/doi/full/10.1177/0963689718816989